Results 201 to 210 of about 108,878 (236)

Lipidomics reveals biomarkers of the efficacy of first-line ICI therapy combined with chemotherapy in NSCLC. [PDF]

J Transl Med
Yu J, Xu H, Xiong F, Liu X, Lingfei M, Gao H, Li Y.   +6 more
europepmc   +1 more source

Diagnostic and prognostic roles of endothelial- and platelet-derived extracellular vesicles in cardiovascular diseases. [PDF]

J Transl Med
Di Febo R, Saeed Z, Serafini F, Brocco D, D'Ascanio F, Pizzi AD, Tinari N, Crescitelli R, Lanuti P, Renda G.   +9 more
europepmc   +1 more source

Clinical Images: Vasculitic rash as a presenting symptom of heparin-induced thrombocytopenia in a woman with primary antiphospholipid syndrome. [PDF]

ACR Open Rheumatol
Elam RE, Thompson K, Saha R, Qureshi A, Powell M, Elam JC, Carter G, Kutlar A.   +7 more
europepmc   +1 more source

Natural Antioxidants and Aquatic Animal Health. [PDF]

Antioxidants (Basel)
Jia R.
europepmc   +1 more source

Author Correction: ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway. [PDF]

Acta Pharmacol Sin
Li S, Yang H, Li W, Liu JY, Ren LW, Yang YH, Ge BB, Zhang YZ, Fu WQ, Zheng XJ, Du GH, Wang JH.   +11 more
europepmc   +1 more source

Lipidome atlas of p53 mutant variants in pancreatic cancer. [PDF]

Biol Direct
Cotton K, Comer C, Caporali S, Butera A, Gurres S, Capradossi F, D'Alessandro A, Amelio I, Niklison-Chirou MV.   +8 more
europepmc   +1 more source

Transmembrane thiol isomerase TMX1 inhibits fibrin formation by down-regulation of platelet phosphatidylserine exposure. [PDF]

Cell Commun Signal
Zhao Z, Zhang Y, Cheng Y, Chen X, Lu Y, Han Y, Wu Y, Yang A.   +7 more
europepmc   +1 more source

Update on the Laboratory Diagnosis of Lupus Anticoagulant: Current Challenges and Clinical Involvement. [PDF]

J Clin Med
Marco-Rico A.
europepmc   +1 more source

Anti-Tumor Effects of Cecropin A and Drosocin Incorporated into Macrophage-like Cells Against Hematopoietic Tumors in <i>Drosophila mxc</i> Mutants. [PDF]

Cells
Hirata M, Nomura T, Inoue YH.
europepmc   +1 more source

Mice with reduced protease-activated receptor 4 reactivity show decreased venous thrombosis and platelet procoagulant activity. [PDF]

J Thromb Haemost
Knauss EA, Guci J, Luc N, Disharoon D, Huang GH, Gupta AS, Nieman MT.   +6 more
europepmc   +1 more source